RSS | Visita nuestra web 
Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) has just filed a shelf registration that would allow the company to sell up to $75 million in securities. The offering can be in stock, debt, warrants, or preferred shares. The use of proceeds is for general corporate purposes. There is just one small problem: The company’s market cap is $73.6 million shares. Oculus has developed, manufactures, and sells a family of products intended to prevent and treat infections in chronic and acute wounds. Its platform Microcyn is a proprietary oxychlorine small molecule formulation that is designed to treat a wide range of organisms…
…
Original Source
13 February, 2008| Economy |
@ 22:12
Categories:
Recent Comments